Search results
Processa reports positive Phase 1b trial results for cancer drug By Investing.com
Investing.com· 7 days agoProcessa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage pharmaceutical company, has announced...
Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the...
FOX 23 News Albany· 8 hours agoGan & Lee Pharmaceuticals (Shanghai Stock Exchange: 603087) announced today the presentation of three abstracts featuring their investigational products at the American Diabetes Association's ...
Will Fort Worth Stockyards lose historic character with $1B expansion? Here’s what we know
Fort Worth Star-Telegram McClatchy via AOL· 2 days agoWhile city leaders are mostly impressed by a proposed nearly $1 billion expansion of the Stockyards,...
DeSantis slashes $68.8 million from state budget in projects for Miami-Dade and Broward
Miami Herald via AOL· 5 days agoLocal programs in Miami-Dade and Broward focused on youth crime prevention, pedestrian safety and...
...Presents Late-Breaking Clinical Data at EHA2024 from Ongoing Phase 1b Study of ELA026 in...
Benzinga· 2 days agoElectra Therapeutics, Inc., a clinical stage biotechnology company developing antibody therapies against novel targets for immunological diseases and cancer, announced the presentation of clinical ...
Judge, Harper lead early All-Star Game fan vote
ESPN· 15 hours agoAaron Judge of the New York Yankees and Bryce Harper of the Philadelphia Phillies lead the initial results in Phase 1 of fan voting for the 2024 MLB...
NodThera's NLRP3 inhibitor shows further anti-inflammatory promise in phase 1b/2a obesity trial
FierceBiotech· 6 days agoNow, an early readout from a study in humans with obesity has again demonstrated the drug’s anti-inflammatory potential. The phase 1b/2a trial saw patients ...
SIA Engineering's (SGX:S59) Returns On Capital Not Reflecting Well On The Business
Simply Wall St. via Yahoo Finance· 1 day agoIf you're looking at a mature business that's past the growth phase, what are some of the underlying...
iTeos Therapeutics (NASDAQ:ITOS) Receives “Outperform” Rating from Wedbush
ETF DAILY NEWS· 7 hours agoWedbush restated their outperform rating on shares of iTeos Therapeutics (NASDAQ:ITOS – Free Report) in a report issued on Monday morning, RTT News reports. The firm currently has a $21.00 price ...
No Mariners Position Players Fare Well in First All-Star Game Voting Update
Sports Illustrated· 8 hours agoThe Seattle Mariners may be faring well in the standings this season, but they are not faring well in the All-Star Game voting. The All-Star Game, which will be played next month in Arlington ...